Form 8-K - Current report:
SEC Accession No. 0001193125-24-217296
Filing Date
2024-09-11
Accepted
2024-09-11 16:49:02
Documents
18
Period of Report
2024-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d892276d8k.htm   iXBRL 8-K 32570
2 EX-1.1 d892276dex11.htm EX-1.1 194994
3 EX-5.1 d892276dex51.htm EX-5.1 6521
4 EX-99.1 d892276dex991.htm EX-99.1 9136
5 EX-99.2 d892276dex992.htm EX-99.2 9392
9 GRAPHIC g892276dsp50.jpg GRAPHIC 6455
  Complete submission text file 0001193125-24-217296.txt   447536

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rlay-20240909.xsd EX-101.SCH 2839
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlay-20240909_lab.xml EX-101.LAB 17236
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlay-20240909_pre.xml EX-101.PRE 10805
20 EXTRACTED XBRL INSTANCE DOCUMENT d892276d8k_htm.xml XML 3501
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 241293121
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)